1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with f-chemotactic peptide in 2 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (f-chemotactic peptide) | Trials (f-chemotactic peptide) | Recent Studies (post-2010) (f-chemotactic peptide) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 79 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Healy, CT; Moreira-Ludewig, R | 1 |
| Advani, SH; Bhisey, AN; Kumar, A; Naik, NR; Radhika, V; Thennarasu, S | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and f-chemotactic peptide
| Article | Year |
|---|---|
A rapid microtiter plate method for the detection of lysozyme release from human neutrophils.
Topics: Amino Acid Sequence; Benzophenones; Cell Separation; Complement C5a; Humans; Leukotriene B4; Methods; Molecular Sequence Data; Muramidase; Neutrophils; Oligopeptides; Platelet Activating Factor; Protamines | 1992 |
Granulocytes from chronic myeloid leukemia (CML) patients show differential response to different chemoattractants.
Topics: Chemotactic Factors; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Platelet Activating Factor; Receptors, Formyl Peptide; Receptors, Immunologic; Receptors, Peptide; Reference Values | 1996 |